[Epidemiology and clinical characteristics of human metapneumovirus]

Zsófia Gáspár1,2, Bálint Tresó3, Laura Kocsis3

  • 11 Dél-pesti Centrumkórház - Országos Hematológiai és Infektológiai Intézet, Infektológiai Osztály Budapest, Albert Flórián út 5-7., 1097 Magyarország.

Orvosi Hetilap
|July 20, 2025
PubMed

Insights

Human metapneumovirus (hMPV) infections can lead to severe respiratory complications, particularly in older adults and those with underlying conditions. Early hMPV diagnostics are crucial for high-risk groups to prevent severe outcomes.

Area of Science:

  • Virology
  • Infectious Diseases
  • Epidemiology

Background:

  • Human metapneumovirus (hMPV) is an emerging respiratory pathogen with increasing recognition, highlighted by recent case reports and the COVID-19 pandemic.
  • hMPV can cause severe respiratory illness, especially in vulnerable populations, necessitating a better understanding of its clinical impact.

Purpose of the Study:

  • To retrospectively analyze the epidemiological and clinical characteristics of hMPV infections in adult patients.
  • To identify risk factors and complications associated with hMPV infection.

Main Methods:

  • A single-center, retrospective cohort study included 80 adult patients with confirmed hMPV infection via RT-PCR between December 2019 and December 2024.
  • Data collected included demographics, comorbidities, clinical presentation, viral co-infections, and complications such as hospitalization, oxygen requirement, pneumonitis, ICU admission, mechanical ventilation, and mortality.

Main Results:

  • A complicated course was observed in 10% of patients, significantly more frequent in older individuals (p=0.05).
  • Pneumonitis occurred in 45% of cases, with 42.5% requiring hospitalization and 30% needing oxygen. ICU admission and mechanical ventilation were required in 8.75% and 6.25% of cases, respectively. In-hospital mortality was 6.25%.

Conclusions:

  • hMPV infection poses a significant clinical threat, particularly to immunocompromised individuals, the elderly, and those with chronic respiratory diseases.
  • Expanding diagnostic testing to include hMPV is vital for early detection and management, especially in high-risk populations, to mitigate severe outcomes.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
529
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
571
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
333
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
447
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.5K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
453